(S)-7-羟基-6,8-二氧-3,4,6,8,12,12A-六氢-9-羧基-2H-吡啶并[1',2':4,5]吡嗪并[2,1-B][1,3] 噁嗪烷、1246616-73-8 C

   2024-11-01 IP属地 广东0
 

 中文名称: (S)-7-羟基-6,8-二氧-3,4,6,8,12,12A-六氢-9-羧基-2H-吡啶并[1',2':4,5]吡嗪并[2,1-B][1,3] 噁嗪烷  

 中文别名: (4R,12AS)-3,4,6,8,12,12A-六氢-7-羟基-4-甲基-6,8-二氧代-2H-吡啶并[1',2':4,5]吡嗪并[2,1-B][1,3]恶嗪-9-羧酸;度鲁特韦中间体2;(S)-7-羟基-6,8-二氧-3,4,6,8,12,12A-六氢-9-羧基-2H-吡啶并[1',2':4,5]吡嗪并[2,1-B][1,3] 噁嗪烷;度鲁特韦杂质F;多替拉韦杂质9;度鲁特韦杂质25 DOLUTEGRAVIR IMPURITY 25;度鲁特韦杂质25;度鲁特韦杂质62  

 英文名称: (S)-7-羟基-6,8-二氧-3,4,6,8,12,12A-六氢-9-羧基-2H-吡啶并[1',2':4,5]吡嗪并[2,1-B][1,3] 噁嗪烷  

 英文别名: Dolutegravir Impurity F;Dolutegravir impurity 7/(4R,12As)-7-Hydroxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2h-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxylic Acid;(S)-7-hydroxy-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxylic acid (Related Reference);(S)-7-hydroxy-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxylic acid;(4R,12aS)-3,4,6,8,12,12a-Hexahydro-7-hydroxy-4-methyl-6,8-dioxo-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxylic acid;(4R,12aS)-7-hydroxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxylic acid;Dolutegravir Intermediates1;(4R,12aS)-7-Hydroxy-4-Methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-[1,3]oxazino[3,2-d]pyrido[1,2-a]pyrazine-9-carboxylic acid  

 CAS号: 1246616-73-8  

 EINECS号: -  

 分子式: C13H14N2O6  

 分子量: 294.26  

 InChI: -  

 分子结构:  

 密度: -  

 熔点: --  

 沸点: -  

 闪点: -  

 折射率: -  

 蒸汽压: -  

 物化性质: -  

 产品用途: -  

 危险品标志: -  

 风险术语: -  

 安全术语: -

举报收藏 0评论 0
  • quote
    加关注0
  • 没有留下签名~~
相关行情
推荐行情
点击排行